Clinical Trial Update: Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

View source ↗

Summary

Abbott's Assert-IQ Implantable Cardiac Monitor post-market study is currently active but not recruiting, tracking outcomes in patients with atrial fibrillation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Arrhythmia

Drugs mentioned

• Assert-IQ Implantable Cardiac Monitor

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Fibrillation Paroxysmal, Atrial Fibrillation, Persistent | Status: ACTIVE_NOT_RECRUITING